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A B S T R A C T
The cerebrospinal fluid (CSF) is a waterly, colorless fluid contained within the brain ventricles and the cranial
and spinal subarachnoid spaces. CSF physiological functions range from hydromechanical protection of the
central nervous system (CNS) to CNS modulation of developmental processes and regulation of interstitial fluid
homeostasis. Optic nerve (ON) is surrounded by CSF circulating in the subarachnoid spaces and is exposed to
both CSF (CSFP) and intra ocular (IOP) pressures, which converge at the lamina cribrosa (LC) as two opposite
forces. The trans–lamina cribrosa pressure gradient (TLPG) is defined as IOP - CSFP and its alterations (due
either to an elevation in IOP or a reduction in ICP) could result in structural damaging of the ON, including
glaucomatous changes.
The purpose of this review is to update the readers on the CSF contribution in controlling the functions/
dysfunctions of ON by regulating homeostasis at LC. We also highlight emerging parallelisms regarding the
expression of cilia-related genes in the regulation of common functions of body fluids in both brain and eye
structures.
1. Introduction
CSF is the nutrient-rich fluid that bathes the brain and spinal cord. It
is continuously secreted into the cerebral ventricles by the choroid
plexus (CP), a layer of surrounding a core of capillaries, and it is ab-
sorbed into the venous system. CSF plays an essential role in the
homeostasis of the interstitial fluid of the brain parenchyma and the
regulation of neuronal function [1–3]. Indeed, CSF composition is
tightly controlled and includes amino acids, vitamins, minerals, ions,
growth factors and signalling molecules that are kept at very specific
concentrations depending on the developmental stage [4]. Ad-
ditionally, CSF helps to cushion the central nervous system from me-
chanical injury. Alterations in CSF dynamics and composition are re-
sponsible for the major alterations of cerebral homeostasis and
physiology observed in hydrocephalus and dementia disorders [5].
A first mention of a mysterious fluid inside the brain is found in the
writings of the ancient Egyptians (1700 BCE) [6]. In Greece,
Hippocrates (129–219 AD) also reported the presence of “water inside
the head” in hydrocephalus subjects, while Galen of Pergamon
(129–200/216 CE) described a “vaporous and smoky” secretion at the
base of the brain, arising from the blood vessels as a “vital spirit”. The
succession of events orchestrating the development of brain ventricular
cavity-CSF system is quite uniform across mammalian species. The CSF
formation rate appears to increase gradually during ontogenesis, sup-
porting the functional importance of the CSF in regulating the devel-
opment of CNS [7]. The CSF formation rate has been measured, for
example, in turtles (1.4 μl/min), rats (2.2 μl/min), rabbits (8–11 μl/
min), cats (14–21 μl/min), monkeys (19–35 μl/min), and goats (160 μl/
min μl/min) [8,9]. In rats and many other species the gradual increase
of CSF formation during postnatal development correlates with post-
natal morphological and functional maturation of choroidal epithelium
[10]. However, the ontogeny and phylogeny of the “vital spirit” around
which the vertebrate brain is organised is not fully understood yet.
Beyond vertebrates, the CSF system is hypothesized to appear in the
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deuterostome lineage as a way to maintain the chemical environment
required for the functioning of CNS cells, including the neuroendocrine
pathways. Earlier in the phylum Chordata, the cephalochordate am-
phioxus includes a larval stage in which the CNS is open through the
neuropore, thus allowing seawater to enter the ventricular lumen.
However, after metamorphosis, the anterior neuropore closes and the
brain becomes a closed system, with a proper CSF regulating brain
development and homeostasis [11]. Strikingly, one main innovation at
early stages of vertebrate origins was probably a heterochronic switch
to an early closure of the neuropore during embryogenesis (and also,
the secretion of an embryonic-eCSF distinct from the adult CSF), which
translated into an early isolation of the brain cavities from the sur-
rounding external media, hence enabling a higher level of internal
control and regulation (Fig. 1; reviewed in [12] and [13]).
The ON develops from the optic vesicle, an outpocketing of the
forebrain, and can be considered part of the CNS [14]. As a CNS
structure, the ON is myelinated by oligodendrocytes, ensheathed in the
cranial meningeal layers and surrounded by CSF circulating within the
subarachnoid space [14]. Recently, many studies have demonstrated
that an imbalanced pressure exercised by CSFP induce structural da-
mage of the ON [15,16]. CSFP, together with IOP, create a pressure
gradient at the LC, a specialized region at the optic nerve head (ONH).
TLPG imbalance could be a major determinant for the pathophysiology
of several eye diseases, such as glaucoma.
In this review, we aim to describe what is known about CSF phy-
siological contribution to maintain LC homeostasis and its potential as a
pathophysiologic factor in ONH diseases. We highlight the CSF theory
of glaucoma, a collection of diseases characterized by progressive de-
generation of the ON cells that represent a leading cause of irreversible
blindness worldwide. Finally, we highlight emerging parallelisms in the
expression of genes controlling the function/dysfunction of body fluids
circulating in both brain and neurosensory organs.
2. Cerebrospinal fluid: an extraordinarily dynamic fluid flowing
through CNS
The developmental processes giving rise to the highly compart-
mentalized CNS architecture are complex and require a series of ex-
quisitely-regulated events. The vertebrate ventricular system develops
from the single cavity inside the neural tube. During the process of
neurulation, the neural plate folds longitudinally and the amniotic fluid
is captured inside the nascent neural tube. The center of the neural tube
forms the ventricular space, surrounded by a pseudo-monostratified
neuroepithelial cells that rapidly divide to expand the neural progenitor
cell pool [17]. The first CP appears shortly after the neural tube closure
in the fourth ventricle as a specialized vascular epithelium producing
CSF. CSF regulates cell replication, cell survival and neuronal differ-
entiation, through both pressure and biochemical mechanisms
[11,18,19]. The subsequent neuroepithelium patterning and re-
gionalization will give rise to the distinct regions of the mammalian
brain. After the formation of the ventricular system, CSF flows from the
CP through the lateral ventricle, the interventricular foramen of Monro,
the third ventricle, the cerebral aqueduct of Sylvius and the fourth
ventricle. Therefore, CSF fills the central canal of the spinal cord and is
passively absorbed into the venous system. Importantly, embryonic CSF
(eCSF) contains three-fold more protein than the adult CSF, further
highlighting its important roles during embryonic development [20].
Homeostasis of the neural microenvironment depends on the ef-
fective separation of this environment from the blood. In parallel, a
sophisticated regulation of the electrolyte balance, an efficient ex-
change of metabolic waste products and a dynamic circulation of nu-
trients, are also required. The CSF meets these requirements and acts as
a key interface that guarantees both hydromechanical protection and
neuraxis compartmentalisation, even so allowing dynamic exchanges.
2.1. Cerebrospinal fluid production and composition
In the human brain, about 75% of CSF is secreted by the CP, and the
additional 25% is contributed by the extracellular fluid (ECF) of the
neuropil, with which the CSF extensively communicates through the
ependymal cells layer.
Normal CSF production is 0.20-0.35ml/min or 600−700ml per
day. Total volume of CSF in an adult is about 150ml, distributed be-
tween 125ml in cranial and spinal subarachnoid spaces and 25ml in
the brain ventricles. Pulsations coming from arterial CP and ependymal
cells cilia allow CSF circulation. On the other hand, CSF can be ab-
sorbed into the venous circulation as well as into lymphatic vessels
[21].
Fig. 1. Phylogeny and evolution of CSF.
Metazoan phylogeny classifies animals with
bilateral symmetry in Protostomia and
Deuterostomia. Protostomia includes clades
Priapulida, Nematoda, Arthopoda,
Platyhelminthes, Mollusca and Annelida. The
sister group of Protostomia are the
Deuterostomia, including Ambulacraria
(Echinodermata and Hemichordata) and
Chordata (Urochordata, Cephalochordata and
Vertebrata). Evolution of CSF system across the
different phyla and subphyla is indicated
(*).CSF, cerebro-spinal fluid; eCSF, embryonic
cerebro-spinal fluid.
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CSF is composed of 99.13% of water, with a pH of 7.33. Other
components are proteins (35mg/dL), glucose (60mg/dL), Sodium
(114.0 mEq/L), Potassium (3.00 mEq/L), Magnesium (2.0–2.5 mEq/L),
Chloride (119 mEq/L). Several studies have demonstrated the existence
of chronobiological variations in CSF secretion, probably related to
circadian differences in the activation of the autonomous nervous
system [22,23]. CSF from the adult lumbar region contains 15–45mg/
dl protein and CSF cell count ranges from 0 to 5 cells per milliliter.
Biochemical and physical examination of the CSF chemical contents
may provide important diagnostic information in a number of medical
conditions. For instance, the 42 aa form of beta amyloid (Aβ42) and
both total- and phosphorylated tau (t-tau and p-tau) concentration in
CSF can be used as Alzheimer's disease (AD) biomarkers [24,25].
2.2. Cerebrospinal fluid pressure
CSFP is defined as the intracranial pressure in the prone position.
The normal range of CSFP is defined between 10 and 15mmHg in
adults and 4.4 and 7.3mmHg in newborns. CSFP variations are most
due to jugular venous pressure, pulse wave, respiratory cycle, physical
activity and posture. The first procedures described to drain CSF by
lumbar puncture date back to the end of the nineteenth century [26].
Currently, CSF pressure can be measured by invasive techniques in-
volving pressure transducers placed in the brain parenchyma or con-
nected to CSF spaces via an external drain. The development of non-
invasive methods is limited to using a transcranial Doppler ultrasound
system or recording the electrophysiological activity of tympanic
membranes [27]. More recent studies described a reliable non-invasive
method to predict CSFP based on trans-ocular venous and arterial he-
modynamic measurements [28]. Other groups have described multi-
variate algorithms-based methods incorporating systemic parameters
such as age, blood pressure and body mass index as indirect indicators
of CSFP [29]. All the physiological processes regulating CSF secretion,
circulation and absorption are involved in CSFP determination. For
instance, the CSF concentration of both atrial natriuretic and arginine
vasopressin neuropeptides (ANP and AVP) are known to increase with
increasing CSFP, as it does the expression of these hormone receptors in
the choroidal epithelium. The final effect is a reduction of CSF chor-
oidal secretion, which in turn induces a dilatation of pial arteries, with
a consequent reduction of cerebral perfusion pressure [30]. However,
we are still far from a comprehensive understanding of the mechanisms
regulating CSFP.
3. The relevance of cerebrospinal fluid for eye physiology
Retina, the light sensing tissue lining the inner surface at the back of
the eye, matures from an evagination of the brain during fetal devel-
opment and can be considered an integral part of the CNS. Light stimuli
processed by photoreceptor cells in the retina are transmitted
throughout the retinal neuronal network until reaching the retinal
ganglion cells (RGC), whose axons form the ON, a cable–like grouping
of nerve fibers. The ON leaves the intracranial space, extends from the
optic disc to the optic chiasma and transmits the vision signals to the
lateral geniculate body, where visual information is relayed to the brain
visual cortex.
The orbital portion of the ON is surrounded by CSF circulating
within the intracranial subarachnoid space. LC is the structural element
of the ONH and it represents a barrier between the intraocular space,
which has a higher pressure, and retrobulbar space, with a lower
pressure. Indeed, a TLPG is formed across the LC [31–33] (Fig. 2).
The theory of glaucoma being a two-pressure disease was initially
proposed by Volkov in the 1970s, and more recently by Berdahl and
Ren [15,34–36]. They wondered whether abnormal pressure outside
the eye might cause normal tension glaucoma, a condition in which the
glaucomatous subjects have normal intraocular pressure (IOP), while
CSFP is lower than normal [37]. This theory was supported by studies
conducted in astronauts, which commonly experience visual dis-
turbances with disc swelling. Six month-long space flights frequently
lead the astronauts to develop a clinical syndrome named spaceflight-
associated neuro-ocular syndrome (SANS), bearing marked similarities
to idiopathic intracranial hypertension with papilloedema [38]. This
phenotype could be explained as a consequence of the absence of
gravity, which allows CSF to diffuse equally through the intracranial
subarachnoid space, thus increasing venous pressures and producing a
higher CSFP at the eye [39].
In summary, ONH healthy state depends on the balance between
IOP, CSFP and the mean arterial blood pressure. Therefore, a strong
interest is emerging concerning the influence of CSFP upon the pressure
gradient at ONH. Changes in this gradient may be a fundamental
component in disorders such as glaucoma, idiopathic intracranial hy-
pertension and venous occlusions.
3.1. LC anatomy: pressure gradient forces at stake
LC is a thin porous tissue formed by collagen-rich “beams” sur-
rounding capillaries. It is located at the base of ON, where the fibres exit
the eye through a hole in the sclera [40]. The LC has an average dia-
meter of 1.7mm and is formed by 200–400 pores of varying sizes
through which approximately 1 million axons exit the eye [41]. LC is
principally composed by laminin, elastin and collagens, and provides
mechanical support [42]. Moreover, LC is the substrate for two types of
cells that provide homeostatic and trophic support to the axons [43].
The first population, formed by GFAP-positive cells with multiple long
and thin cellular processes, are identified as astrocytes. They draw
nutrients from capillaries that run within the connective tissue beams.
A second cell type, characterized by a large, flat morphology and ne-
gative for GFAP, are named LC cells. They share behavioural and mo-
lecular features with astrocytes population, which suggest that LC cells
are also a subtype of astrocytes [44].
The posterior part of the LC faces the anterior region of the ONH.
Importantly, this ON region is unmyelinated and closely associates with
astrocytes. These features entail specific metabolic requirements and
differential responses to metabolic stress, as we will describe below.
As part of the CNS, the ON is surrounded by the meninges and CSF,
which also exercises a force upon the ONH. The internal pressure within
the globe of the eye (IOP) and external pressure exerted by the tissues
surrounding the posterior region of the eye converge on the LC, creating
a region of stress concentration surrounding the ONH [45]. The trans-
lamina cribrosa pressure difference (TLPD) is defined as the difference
between the IOP and the retrobulbar pressure [33], and this parameter
is relevant for the physiology and pathophysiology of the ONH. TLPD
Fig. 2. Histologic anatomy of a normal optic head nerve. The LC (red) is a
thin structure located at the base of the ON. The nerve fibres exit the retinal
neuronal layers (green) and run through the lamina cribrosa pores. The ON is
surrounded by CSF (blue) flowing through the intracranial subarachnoid space.
S. Mirra, et al. Seminars in Cell and Developmental Biology xxx (xxxx) xxx–xxx
3
alterations are presumed to cause axonal damage in glaucoma, leading
to either structural damage on the retinal ganglion cells axons (me-
chanical hypothesis), with consequent neuroinflammation and altera-
tions in axonal transport dynamics, and/or constriction of blood flow
within the lamina’s tissue (hemodynamical hypothesis) [46–49].
Remarkably, LC is a dynamic component in vivo. The LC bio-
mechanical properties allow movements in both sagittal and coronal
directions. Sagittal movements are linked to pulse-synchronous changes
in the TLPD and are mechanically limited by the ONH. On the other
hand, coronal movement are induced by central retinal vein pulsations.
Importantly, CSFP contributes to calibrate the LC movement, even if
indirectly, since it influences both TLPD and the central retinal vein
pressure. Regarding the physiological function of LC movements, sev-
eral hypotheses have been postulated, e.g. some groups hypothesize
that LC movements would follow through and facilitate orthograde and
retrograde axoplasmic flow through the eye [50–52]. Therefore, even if
the physiological importance of LC positional oscillations is still far to
be elucidated, CSFP may play a pathophysiological role in this context.
3.2. Metabolic stress at LC
Axonal changes described in glaucoma animal models satisfactorily
resume the complex spectrum of physiological alterations occurring at
ONH when the TLPG is impaired. One of the first alterations observed
in early stages of glaucoma is the inhibition of axonal transport at LC,
with consequent accumulation of organelles. Organelle arrest has been
described in both ONH prelaminar and postlaminar regions in monkey
models of experimental glaucoma [53], as well as in the glial lamina of
rat models of early-onset glaucoma [54]. This phenomenon can be
correlated with molecular changes involving motor proteins and cy-
toskeleton structures that are vital for axonal organelle trafficking.
Significant changes in cytoskeletal protein levels have been described in
pig and rat models of glaucoma [55]. Kinesin-1 levels decrease sig-
nificantly in the prelaminar ONH during ocular hypertension [56],
whereas dynein levels become elevated in the retrolaminar region [57].
The mechanism hypothesized to explain the blockages of axonal
transport at the LC is the hiperactivation of kinesin-1 degradation
pathway, leading to the lamina obstruction and/or cell soma dis-
connection.
RGC survival and function are highly dependent on the energy
supplied by mitochondrial activity. The absence of myelinisation makes
the axons at LC highly energy demanding. This condition is reflected by
the high mitochondrial concentration at both prelaminar and laminar
regions of RGC axons [58]. Elevated IOP may locally compromise the
blood supply or its regulation in the lamina, contributing to metabolic
stress. Cytochrome oxidase activity increases in the collagenous lamina
region of the pig ON when TLPG increases, indicating a significant
growth of metabolic requirements in this region [32]. High IOP directly
impacts mitochondrial functions in DBA/2 J mice by promoting
reduction of cytochrome c oxidase IV subunit 1, and leading to a de-
crease in ATP levels and cristae depletion. In addition, alterations in
proteins regulating mitochondrial dynamics, such as OPA1 and Dnm1,
have been described in animal models with increased IOP [59–61].
3.3. The ocular glymphatic system: a recent, intriguing hypothesis
The glymphatic system is an exquisitely organized brain-wide me-
chanism by which CSF flows through a para-arterial route to enter the
brain parenchyma. This pathway allows the potentially toxic metabolic
products to be removed from the interstitial fluid (ISF) in the brain and
be returned to the CSF and, eventually, to the lymphatic system. It is
largely known that CNS blood vessels are covered by astrocytes and
surrounded by perivascular space, and several hypotheses about peri-
vascular space significance have been proposed over many years, until
2012, with the work by Iliff et al. These authors used in vivo two-photon
and ex vivo fluorescence imaging to demonstrate that tracers injected in
CSF could be transported along periarterial space [62]. Then, the CSF
influx flows into brain parenchyma driven by arterial pulsation forces
where it merges with ISF [63]. The mixed CSF and ISF with interstitial
metabolic waste flow towards paravenous pathways and reach the
lymphatic system (Fig. 3.a). Further data supporting the possible im-
plication of glymphatic system dysfunctions in promoting human dis-
ease were later provided. They also observed that amyloid-beta peptide
and Tau proteins could be partially eliminated from the brain par-
enchyma through the perivenous spaces [62,64]. Aquaporin-4 (AQP4)
water channels, abundantly expressed in astrocytic end-foot processes
ensheathing the cerebral vasculature, guarantees glymphatic clearance.
In mice lacking the AQP4 gene, amyloid-beta clearance is reduced by
approximately 55% [64].
An additional function carried out by the glymphatic system may
concern the correct distribution of non-waste compounds, such as
glucose, lipids, amino acids, and neurotransmitters in the brain [65].
A rapidly evolving literature is proposing that an “ocular glym-
phatic system” also exists in the eye and may be relevant to a large
number of ocular diseases [66]. Yet the eye, like the brain, has no
traditional lymphatic vessels while still needing to clear potentially
neurotoxic protein waste. Furthermore, the presence of AQP4 in human
ON sections has been recently demonstrated [67]. Several animal
models were used over the years to inject tracers into CSF to be detected
in the ON [68]. However, the route of entry was neither described nor
assumed to be free diffusion from the subarachnoid space. The first
evidence of CSF entry through the ON along paravascular spaces was
obtained in mice [69]. CSF was postulated to flow through a para-ar-
terial CSF route around the central retinal artery and enter into the
paravascular spaces of the retina; then, a para-venous clearance efflux
route might travel around the central retinal vein [70] (Fig. 3.b). In this
scenario, the LC may mechanically interfere with the glymphatic flow
between the ON and retina, at least in glaucomatous eyes, where the LC
Fig. 3. Glymphatic Pathway Function. a) CSF flows through brain tissue from perivascular space facilitated by aquaporin-4 water channels positioned within
perivascular astrocyte end-foot processes. The bulk movement of CSF into the brain drives the flow of interstitial solute through the extracellular space to ultimately
collect within perivenous spaces. b) Schematic representation of the “ocular glymphatic system” hypothesis postulated by Wostyn et al. [70].
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structure is highly altered. As a consequence, the elimination of neu-
rotoxic substances from the retina would be impaired, ulteriorly pro-
moting the glaucomatous damage. Consistently, studies in glaucoma-
tous animal models showed that Aβ is a likely mediator of pressure-
induced RGC death [71]. Therefore, the discovery of a glymphatic
system in the eye may be particularly relevant to understand the me-
chanisms underlying several neurodegenerative ocular diseases. Yet,
the existence of an ocular glymphatic system in the human eye remains
only a hypothesis, and much more studies are needed to validate it.
4. CSF contribution to glaucomatous ON damage
Normal-tension glaucoma (NTG) is a condition characterised by
visual field loss and optic disc excavation identical to primary open-
angle glaucoma (POAG) despite apparently normal IOP. Initially, NTG
was related to vascular deregulation leading to an impaired blood flow
to the ONH. Later on, a new hypothesis involving the CSFP factor was
appropriately formulated. A relatively low CSFP may generate me-
chanical conditions acting on the OHN similar to a relatively elevated
IOP.
The first studies aimed to strengthen the hypothesis of glaucoma as
a two-pressure disease were performed in cat and dog models several
decades ago [72,73], but a large amount of clinical retrospective studies
were later reported. Patients with high-pressure POAG were found to
have lower CSF compared to normal patients [35,74]. Similarly, ocular
hypertension patients showed higher CSFP compared to controls
[35,74]. Interestingly, a positive correlation between translaminar
pressure and patient’s visual field loss was described [74]. In a more
recent study, no significant differences between NTG patients and
healthy controls with respect to CSFP or TLPG were reported [75].
However suggestive, all these studies included a limited number of
subjects, which precluded strong statistical significance.
Noteworthy, several limitations should be considered in studying
TLPG: i) while IOP is measured at the cornea, CSFP was generally
measured at the lumbar level and not in the orbital space; ii) LC bio-
mechanical properties largely depend on individuals differences that
determine how susceptible the axons are to this stress; iii) changes in
body position affect both CSFP and IOP so that studies performed by
measuring patient’s CSFP in a sitting position and ICP in supine position
compromise TLPG evaluation and comparison; and iv) IOP and CSFP
follow a circadian rhythm, therefore simultaneous measurement of IOP
and ICP should be performed in order to obtain a reliable TLPG eva-
luation.
Numerous risk factors have been associated with the development
of glaucoma and notably, some of them could be related to CSFP. These
factors may affect CSFP as a potential risk factor for glaucoma.
Generally, a positive correlation has been detected between increased
Body Mass Index (BMI) and glaucoma, particularly in women [76–78].
Prospective and retrospective studies have shown that BMI is positively
associated with CSFP in different populations [77–79]. The underlying
hypothesis correlates obesity with an increased intra-abdominal and
venous pressure, with a consequent increase in intracranial pressure
[80]. Conversely, some reports support that lower BMI may increase the
risk for glaucoma, or even that increased BMI may be protective
[81,82]. These studies described an association only for women, sug-
gesting that hormonal factors might be involved in regulating specific
molecular pathways in glaucoma [83].
Age is a further well-documented risk factor for glaucoma. Although
some studies that examined CSFP and age failed to find a relationship
[84,85], a recent study provided some evidences relating CSFP to age:
CSFP was stable from ages 20–49 years, but progressively declined in
the 6th decade. Interestingly, the age where CSFP begins to decline
coincides with the age of prevalence increase in POAG [79]. Age-re-
lated decrease in CSFP could induce a relatively significant increase in
the TLPG, thus supporting the idea that reduced CSFP may be a risk
factor for POAG and NTG.
Finally, the impact of genetics in glaucoma is worthy of mention. It
is well known that NPG has a high heritability. Two independent groups
described an association between a single nucleotide polymorphisms
(SNP) of the gene region containing the cyclin-dependent kinase in-
hibitor 2B antisense noncoding RNA (CDKN2B-AS1) and some glau-
coma features among POAG patients [86,87]. Importantly, the
CDKN2B-AS1 gene region is known to influence TGF-beta activity and
to be actively transcribed by the CPE cells that secrete CSF.
5. Overlapping genetic pathways control common functions in
both brain and eye, in health and disease conditions
As largely discussed above, pressure gradient at LC is a resultant of
the net pressure force on the optic disk, determined by the difference
between the ICP and IOP, which in turn depend, respectively, on CSF at
retrobulbar space and aqueous humor (AH) at the eye chamber.
CSF and AH are both produced by layers of neuroepithelial cells
sealed by tight junctions: CSF is secreted from the choroid plexus epi-
thelium (CPE), while AH is produced by the ciliary body epithelium
(CBE). CBE is formed by two adjacent layers: the non-pigmented (NPE)
and the pigmented epithelium (PE), sharing almost identical tran-
scriptomic profiles [88]. In addition to produce colourless fluids in-
volved in homeostatic regulation of CNS parenchyma or ocular tissues,
and regulate pressure dynamics, the CPE and CBE share other common
features [89]. Interestingly, 10 out of 65 POAG candidate disease genes
were found highly expressed in both healthy human CPE and NPE, thus
suggesting overlapping molecular mechanisms that could induce pa-
thological pressure alterations in the two epithelia [90].
Another aspect associating CP and the visual system concerns the
sophisticated mechanisms regulating the production and the home-
ostasis of both CSF and AH. In the same transcriptomic study, common
expression profiles in CPE and NPE were mainly related to genes en-
coding ion channels and ion transporters, such as genes belonging to
ATP1A, KCN, SCN, AQP and SLC families, all playing a key role in CSF
production. Moreover, ion channels and ion transporters are known to
be essential to maintain retinal homeostasis and prevent retinal de-
generation [91]. Thus, the genetic knockout of these genes in experi-
mental animal models is expected to cause severe alterations in both CP
and visual system. In fact, the targeted disruption of Slc4a5 (Slc4a5−/
−), encoding the electrogenic sodium bicarbonate cotransporter
NBCe2, results in abnormal structure of CP epithelial cells in mouse
[92]. As a consequence, CSF pressure and composition are altered and
the volume of lateral ventricles is reduced. Slc4a5−/− mice also de-
velop a severe retinopathy that results in visual impairment. Interest-
ingly, Slc4a5 deletion affects the epithelial tissue in the eye, inducing
rod outer segment tip displacement from the apical RPE plasma mem-
branes, and a dense packaging of RPE apical microvilli. Moreover, ON
degeneration could be indirect consequence of an increased TLPG.
Remarkably, CP and CB biological functions are both highly de-
pending on the physiological contribution of ciliated cells. CPE-lining
brain ventricles deploy hundreds of motile cilia to guarantee CSF cir-
culation. On the other hand, the anterior portion of the ciliary body is
characterized by ciliary structures protruding from CBE. Many other
cells in the eye produce primary cilia (e.g. the retinal pigment epithe-
lium cells, photoreceptors, Müller glia cells) and indeed, ciliated cells
notably contribute to the vertebrate visual system function. Because of
their abundant presence in the human body, genetic mutations re-
sulting in abnormal formation or function of centrioles and cilia give
rise to a wide group of disorders generically known as ciliopathies,
exhibiting a wide range of phenotypes, such as diabetes, eye movement
abnormalities, liver disease, hydrocephalus, infertility, cognitive im-
pairment/defects, retinal degeneration. Emerging evidences from lit-
erature unearth a growing number of genes causing ciliopathies and
several syndromic rare diseases, whose mutations are associated with
both neurosensorial and CSF disorders, displaying pleiotropic pheno-
typic manifestations including hydrocephalia. Here we provide some
S. Mirra, et al. Seminars in Cell and Developmental Biology xxx (xxxx) xxx–xxx
5
examples of ciliopathy-associated genes that may be related to CSF
diseases, such as CEP164, IFT88, BBS1 and TMEM67.
CEP164 belongs to the CEP family of centrosomal proteins, and is
required for assembly of primary cilia. Mutations in CEP164 cause ne-
phronophthisis-related ciliopathies, with a gradient of genotype/phe-
notype correlations in which null mutations cause severe dysplastic
phenotypes, whereas hypomorphic alleles cause milder degenerative
phenotypes. Interestingly, Cep164 conditional knockout in mice shows
that this gene is essential in multiciliated cells because it modulates the
selective transport of membrane vesicles and their cargoes into the
ciliary compartment [93]. The IFT88 protein, a member of the tetra-
trico peptide repeat (TPR) family, is also involved in cilium biogenesis
[94], and has been shown to be relevant for ciliary beating and CSF
flow in zebrafish. Besides, IFT88 has been also localized in the primary
cilium, both in renal cells and photoreceptors, and mutations in the
Tg737 gene cause abnormal outer segment development, retinal de-
generation and polycystic kidney disease in mouse [95]. On the other
hand, BBS1 is one of the genes causative of Bardet-Biedl syndrome-1, a
genetic rare ciliopathy associated with a set of primary and secondary
symptoms, such as retinitis pigmentosa, kidney dysfunction and beha-
vioral dysfunction [96]. BBS1 is highly expressed in retina and the CSF,
and a mouse mutant model show brain megaventricules and severe
alterations in the CP cells. TMEM67 regulates centriole migration
during primary cilium biogenesis, and mutations altering the multiple
isoforms produced by TMEM67 result in ciliopathies, including retinal
degeneration, renal cystic disease and a complex range of anatomical
and functional defects of CNS, including hydrocephalia [97].
On the basis of these evidences, it is tempting to speculate that
genes relevant in primary ciliogenesis are also key for multiciliogenesis.
Pursuing the contribution of ciliopathy genes in CSF disorders is cur-
rently an unexplored but intriguing hypothesis.
6. Conclusions
Like human civilisations developing along riverbanks and seashores,
vertebrate CNS develops around the extraordinarily dynamic and
complex CSF. The strict mechanisms regulating the fine balance be-
tween secretion, composition, pressure and turnover of the primary
fluid within the central nervous system have been refined during evo-
lution. Alterations of this balance are implicated in a wide range of
neurological pathologies: hydrocephalus, idiopathic intracranial hy-
pertension, brain trauma, brain tumours and stroke, among others. The
relevance of CSF in maintaining the healthy state of the eye, formed by
a developmental evagination of the CNS and with a highly specialized
function, is rapidly growing as extensively discussed in this review.
However, researchers are still in the early stages of exploring how this
information can be translated to relevant knowledge for new ther-
apeutic treatments, particularly in glaucoma. Our current inability to
measure cerebrospinal fluid pressure by non-invasive procedures and
quantify the retrolaminar pressure gradient hinder advances in CSFP-
related eye diseases. Moreover, the precise cellular, molecular and
physiological mechanisms that contribute to altered hydrodynamic
pathways in ocular disorders are poorly understood. Notably, data
originated from genomic and transcriptomic studies shed light on novel
genes that could be related with the regulation of fluid flow in both CNS
and neurosensorial structures. Often these are genes expressed by spe-
cialized cells located in different body compartments but sharing
common functions. Consistently, inherited alterations of most of these
genes that regulate nutrients and ion exchange, or liquid flow by ade-
quate ciliary function alter a wide range of physiological processes and
could lead to syndromic pathologies involving not only the brain and
the neurosensorial systems, but also a number of organs such as kidney,
heart or the reproductive system. Comprehensive studies on the bio-
logical processes compromised in patients suffering the pathological
consequence of these molecular and cellular alterations will pave the
way to design effective novel therapies for a wide range of CSF-
associated disorders.
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